Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice
Information source: Consorci Sanitari de Terrassa
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Gynecological Pathology
Intervention: Lidocaine-Prilocaine cream (Drug); placebo (Drug)
Phase: Phase 4
Status: Not yet recruiting
Sponsored by: Consorci Sanitari de Terrassa Official(s) and/or principal investigator(s): Baldomero Arnau Rivera, MD, PhD, Principal Investigator, Affiliation: Consorci Sanitari de Terrassa
Overall contact: Baldomero Arnau Rivera, MD, PhD, Phone: 0034 937314138, Email: barnau@cst.cat
Summary
The purpose of this study is to demonstrate that Lidocaine-Prilocaine cream decrease pain
during hysterosalpingography diagnostic practice.
Clinical Details
Official title: Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice: a Prospective Randomized Double Blind, Placebo-controlled Clinical Trial
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
Primary outcome: pain reduction in the performance of hysterosalpingography
Secondary outcome: sense of discomfort experience during the procedure
Eligibility
Minimum age: 18 Years.
Maximum age: 80 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- patients that must perform a hysterosalpingography
- acceptance to participate in the study signed informed consent
Exclusion Criteria:
- hypersensitivity or allergy to anesthetics
- refusal of the patient
- patients under age 18 years old and pregnant
- unbearable pain that involves other analgesic measures
Locations and Contacts
Baldomero Arnau Rivera, MD, PhD, Phone: 0034 937314138, Email: barnau@cst.cat
Consorci Sanitari de Terrassa, Terrassa, Barcelona 08227, Spain; Not yet recruiting Baldomero Arnau Rivera, Phone: 0034 937314138, Email: barnau@cst.cat Baldomero Arnau Rivera, MD, PhD, Principal Investigator
Additional Information
Starting date: April 2011
Last updated: February 24, 2011
|